24小时热门版块排行榜    

Znn3bq.jpeg
汕头大学海洋科学接受调剂
查看: 562  |  回复: 3

984208320

木虫 (正式写手)

[交流] 【Share】Malaria: New Partnership Aims to Stop Parasite in its Tracks

A new partnership is being launched to develop a malaria vaccine that would prevent parasites from entering the liver. Most of the symptoms of the disease develop after parasites have had time to replicate there.

The World Health Organization estimates that in 2008, there were 247 million cases of malaria worldwide, with one million deaths. It says in Africa, a child dies every 45 seconds from the disease.

The best treatment now available is artemisinin-based combination therapy. But an effective vaccine would be much better. That's the goal of the partnership involving the international, non-profit organization PATH, Merck Pharmaceuticals and New York University.

Finding a weakness

Scientists think they've discovered the Achilles heel of the malaria parasite. After a bite by an infected mosquito, the parasite travels through the bloodstream and arrives at the liver. That's where scientists believe the best line of defense can be made.

Dr. Ashley Birkett is PATH's Malaria Vaccine Initiative director of pre and early clinical development.

"The parasite has a natural affinity for liver cells. Liver cells are the cells that the parasite can actually make copies of itself in once it enters the human body. So, it's goal once it enters the human bloodstream after an infectious bite is to find liver cells. And then it enters those liver cells through a set of specific interactions that we don't fully understand. But there is a critical event in that entry process that we think we can target through a vaccine approach," he says.

He says if the parasite cannot enter the liver, it cannot replicate and cause disease. But targeting a parasite is more difficult than targeting viruses or bacteria.

"This is a parasite," he says, "It's a very complex organism that has over 5,000 different gene products that it makes. It's a lot more complicated than a typical virus. I think also there have been limited resources that have been applied to malaria vaccine development over the years. But we are having significant success now. And through a partnership with GlaxoSmithKline, PATH MVI is engaged in a very large phase-three clinical study, which is a last stage of clinical testing before a vaccine can actually be licensed and start saving lives."

Birkett says the vaccine has been evaluated in 16,000 young children in seven sub-Saharan African countries. It has an efficacy rate of 50 percent.

"So, given that we're looking in the order of 900,000 deaths from malaria in young children primarily per year in sub-Saharan Africa, a vaccine with 50 percent efficacy is actually a very significant achievement. But we want to do better," says Birkett.

The vaccine being tested depends on the body producing very large numbers of antibodies against the malaria parasite. That's makes it more difficult to have a higher efficacy rate. The hope of a new vaccine is to specifically target a different area of the parasite with fewer anti-bodies.

Malaria taking a toll

Dr. Birkett says this would relieve African countries of some heavy burdens.

"We're looking at countries in sub-Saharan Africa, which already have significant burdens to deal with in terms of economic impact of these global infectious diseases. And malaria has a huge economic impact. So a vaccine that can be highly protective and prevent these clinical diseases and up to 900,000 deaths per year is going to have a significant health and economic benefit in these countries," he says.

Dr. Birkett says the cost of such a vaccine would be kept as low as possible. Clinical testing on the proposed vaccine is still three or four years away. Malaria immunization would be included as part of a child's routine vaccinations.
回复此楼

» 猜你喜欢

已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

小木虫(沙发+1,金币+0.5):恭喜抢个沙发,再给个红包
2楼2010-12-15 10:24:20
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

小木虫(金币+0.2):抢了个小板凳,给个红包
3楼2010-12-15 10:24:21
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
4楼2010-12-15 21:35:27
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
相关版块跳转 我要订阅楼主 984208320 的主题更新
普通表情 高级回复 (可上传附件)
最具人气热帖推荐 [查看全部] 作者 回/看 最后发表
[考研] 327求调剂 +23 Xxjc1107. 2026-04-13 25/1250 2026-04-14 18:48 by 逍遥三郎
[考研] 通信工程求调剂!!! +4 zlb770521 2026-04-14 4/200 2026-04-14 18:19 by lbsjt
[考研] 求调剂 +16 雪逢冬 2026-04-10 16/800 2026-04-14 14:27 by 逆水乘风
[考研] 农学0904 312求调剂 +4 Say Never 2026-04-11 4/200 2026-04-14 09:10 by zs92450
[考研] 生物学调剂 +11 小冉要努力 2026-04-10 13/650 2026-04-13 11:46 by 电化学及催化
[考研] 一志愿085802 323分求调剂 +13 drizzle_9 2026-04-12 14/700 2026-04-13 10:26 by Faiz5552
[考研] 322求调剂,08工科 +4 今天是个小号 2026-04-08 4/200 2026-04-13 00:20 by baobaoye
[考研] 22408 352分求调剂 +5 努力的夏末 2026-04-09 5/250 2026-04-12 19:17 by wj165256
[考研] 331求调剂 +5 王国帅 2026-04-11 5/250 2026-04-11 22:56 by 溪涧流水
[考研] 296求调剂 +14 汪!?! 2026-04-08 15/750 2026-04-11 20:28 by dongdian1
[考研] 086003调剂求助 +21 苏弋万 2026-04-09 22/1100 2026-04-11 20:25 by dongdian1
[考研] 283求调剂 086004考英二数二 +17 那个噜子 2026-04-10 18/900 2026-04-11 16:27 by 明月此时有
[考研] 调剂 +5 文道星台 2026-04-11 5/250 2026-04-11 15:01 by 凯凯要变帅
[考研] 085600材料与化工329分求调剂 +16 叶zilin 2026-04-10 16/800 2026-04-11 11:04 by may_新宇
[考研] 085506-求调剂-285分 +3 雷欧飞踢 2026-04-08 3/150 2026-04-11 08:37 by zhq0425
[考研] 调剂 +12 卷卷卷心菜_ 2026-04-09 13/650 2026-04-10 22:36 by Ftglcn90
[考研] 282,电气工程专业,求调剂,不挑专业 +9 jggshjkkm 2026-04-10 9/450 2026-04-10 14:55 by 逆水乘风
[考博] 博士自荐 +7 可可小胖 2026-04-08 7/350 2026-04-10 08:28 by kimhero
[考研] 070300化学 求调剂 +13 73372112 2026-04-08 13/650 2026-04-09 20:22 by maddjdld
[考研] 复试调剂,一志愿郑州大学材料与化工289分 +31 硕星赴 2026-04-08 31/1550 2026-04-09 16:54 by Delta2012
信息提示
请填处理意见